BioCluster Report '08

The OBN BioCluster Report is carried out every three years charting the progress and continued growth and development of the Oxfordshire Biotech Cluster.  The research was carried out from 2007-8 by a full-time MBA qualified Cluster Analyst, with the aim of producing a final product of similar quality to E&Y Beyond Borders.  The BioCluster Report establishes OBN's leadership as the knowledge-holder for an exhuastive database of information about the region's biotechnology and healthcare companies.

The 32 printed-page colour data-rich Executive Summary report summarises the findings of our research on the growth and develompent of the Oxford BioCluster from Q1 2005 - Q4 2007, providing compelling evidence that the Oxford BioCluster has reached critical mass. Snap shot of findings: 142 biotech & healthcare companies in Oxfordshire, nearly 40 venture-backed and 27 public-listed companies, 56 compounds in clinical development, over £460m investment since Q1 2005.

Watch a Powerpoint Presentation about the findings.

Either Download the full colour  "Executive Summary" launched at BioTrinity 2008, or the full report, "The Definitive Guide" (large file - 5MB) with all data tables and a review of over 100 companies based in the Oxford & South-East region.

The full version ("The Definitive Guide") of the report including the data tables was published by OBN on July 22nd 2008 at our "Biotech BBQ" at Milton Park.

Publication Date of the Definitive Guide: July 22nd 2008

Objectives:

> Promote the growth and development of the Oxford Biocluster.
> Promote OBN as the essential network facilitator to the future growth of the cluster.
> The introduction of an interactive service providing an exhaustive database covering Oxford & South East BioCluster accessible via the OBN website.

Implementation

The report will be split into distinct sections covering:

An Overview of the Cluster Dynamic

> Growth of the cluster
> Age profile of companies in the cluster
> Employment impact

Funding

> Total private and public capital raised in Oxford BioCluster over the three years to Q4 2007
> Significant regional financing
> An analysis of the performance of public listed companies
> Active Investor list

Product Development

>  In-depth product pipeline data for the therapeutic companies in Oxfordshire
>  Analysis of key therapeutic areas

Company Locations

>  A detailed analysis of the main cluster locations covering
>  Distribution of life sciences companies across Oxfordshire's science/industry parks
>  Price of office/lab facilities at the various parks
>  Sector breakdown of companies by location (eg. Where are most therapeutics companies located)

Survey Analysis

>  A collective insight into companies personal views on the clusters performance

Sponsorship and Promotional Opportunities

How many will be distributed? 1000 paper copies of the Executive Summary will be distributed, but thousands will be downloaded from the OBN website over three years.  A reprint of the Definitive Guide was distributed at BioTrinity 2009.

£2000 - Sponsor Options Full page A4 colour plate (advertisement), plus chapter association (see below) in the OBN BioCluster Report 2011.

Contact Details

Jon Ree, CEO, OBN jon.rees@obn.org.uk or 0845 5049722